191 related articles for article (PubMed ID: 27185539)
1. Modeling Physical Stability of Amorphous Solids Based on Temperature and Moisture Stresses.
Zhu DA; Zografi G; Gao P; Gong Y; Zhang GGZ
J Pharm Sci; 2016 Sep; 105(9):2932-2939. PubMed ID: 27185539
[TBL] [Abstract][Full Text] [Related]
2. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
3. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
Konno H; Taylor LS
Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
5. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
[TBL] [Abstract][Full Text] [Related]
6. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
8. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
[TBL] [Abstract][Full Text] [Related]
9. Physical Stabilization of Pharmaceutical Glasses Based on Hydrogen Bond Reorganization under Sub-T
Tominaka S; Kawakami K; Fukushima M; Miyazaki A
Mol Pharm; 2017 Jan; 14(1):264-273. PubMed ID: 28043129
[TBL] [Abstract][Full Text] [Related]
10. An improved kinetics approach to describe the physical stability of amorphous solid dispersions.
Yang J; Grey K; Doney J
Int J Pharm; 2010 Jan; 384(1-2):24-31. PubMed ID: 19786081
[TBL] [Abstract][Full Text] [Related]
11. Kinetic stability of amorphous solid dispersions with high content of the drug: A fast scanning calorimetry investigation.
Lapuk SE; Zubaidullina LS; Ziganshin MA; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2019 May; 562():113-123. PubMed ID: 30902705
[TBL] [Abstract][Full Text] [Related]
12. A practical method to predict physical stability of amorphous solid dispersions.
Greco S; Authelin JR; Leveder C; Segalini A
Pharm Res; 2012 Oct; 29(10):2792-805. PubMed ID: 22422318
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
Otsuka M; Kato F; Matsuda Y
AAPS PharmSciTech; 2002; 3(4):E30. PubMed ID: 12916924
[TBL] [Abstract][Full Text] [Related]
14. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
Aucamp M; Milne M; Liebenberg W
AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
[TBL] [Abstract][Full Text] [Related]
15. Modelling drug degradation in a spray dried polymer dispersion using a modified Arrhenius equation.
Patterson A; Ferreira AP; Banks E; Skeene K; Clarke G; Nicholson S; Rawlinson-Malone C
Int J Pharm; 2015 Jan; 478(1):348-360. PubMed ID: 25450477
[TBL] [Abstract][Full Text] [Related]
16. Accelerated stability modeling of recrystallization from amorphous solid Dispersions: A Griseofulvin/HPMC-AS case study.
Leon AS; Waterman KC; Wang G; Wang L; Cai T; Zhang X
Int J Pharm; 2024 May; 657():124189. PubMed ID: 38701906
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.
Bhardwaj SP; Arora KK; Kwong E; Templeton A; Clas SD; Suryanarayanan R
Mol Pharm; 2014 Nov; 11(11):4228-37. PubMed ID: 25325389
[TBL] [Abstract][Full Text] [Related]
18. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
Xie T; Taylor LS
J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
[TBL] [Abstract][Full Text] [Related]
19. Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.
Dengale SJ; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
Eur J Pharm Biopharm; 2015 Jan; 89():329-38. PubMed ID: 25542681
[TBL] [Abstract][Full Text] [Related]
20. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
